Latest Commercialisation News

Insignia Financial Limited will be removed from the S&P/ASX 200 Index ahead of its acquisition by Daintree BidCo, with 4DMedical Limited stepping in on April 20, 2026.

ClearVue Technologies slashed its quarterly cash burn by 52.7%, trimming $6.9 million in annual costs, as it pushes forward with multiple international solar projects and key product certifications.

Axel REE has selected its Woolrich ISR Deposit in Brazil for its first in situ recovery (ISR) rare earth elements field trial, aiming to validate low-cost extraction and downstream processing of mixed rare earth carbonate products.

EMVision Medical Devices has ramped up recruitment in its pivotal FDA trial across eight hospitals and is nearing results from multiple pre-hospital studies, all while bolstering its cash position with a $3.8 million R&D tax refund and $6.6 million in grant funding.

Metallium Limited has marked a pivotal quarter with over 40 Flash Joule Heating campaigns completed and a strategic capital raise boosting cash reserves to A$82 million. The company is gearing up for multi-reactor operation at its Texas campus, underpinned by long-term agreements with Indium Corporation and Glencore.

Critical Resources (ASX:CRR) has launched a systematic surface exploration program at the underexplored Corona Pegmatite Field, aiming to expand its Mavis Lake lithium resource in Ontario, Canada. The initiative complements the Gullwing exploration and supports CRR’s vision of developing a multi-deposit lithium district.

Pure Resources has appointed Rocco Tassone as interim CEO for six months, tasking him with steering the company through a leadership transition and advancing its Garnet Hills Project and thermal management technologies.

Invictus Energy has secured renewal of its Environmental Impact Assessment in Zimbabwe and is poised to execute a key Petroleum Production Sharing Agreement, enabling significant exploration and appraisal activities in the Cabora Bassa Basin.

Fortescue Ltd (ASX: FMG) is fast-tracking the deployment of the world’s first large-scale, fully integrated green energy grid dedicated to heavy industry, aiming to eliminate diesel use across its Pilbara operations by early 2027 and full completion by 2028.

Telix Pharmaceuticals has announced FDA acceptance of its resubmitted NDA for TLX101-Px (Pixclara®), a PET imaging agent for glioma, setting a PDUFA goal date of September 11, 2026. The agent addresses a significant unmet need in distinguishing recurrent glioma from treatment effects.

Elixir Energy and APA Group have partnered to assess the optimal pipeline route for gas from the Lorelle pilot project to Queensland’s Wallumbilla Gas Hub, aiming to support future development decisions.

TMK Energy Limited (ASX: TMK) reported a 48% increase in average daily gas production at its Gurvantes XXXV Coal Seam Gas Project in March 2026, achieving a new peak daily rate before temporarily curtailing output for operational safety. The company also secured a Memorandum of Understanding with Mongolia’s regulator to facilitate power generation and progress towards an exploitation license.